glp 1 not compounded GLP-1/GIP Injections Online FDA is moving to restrict

2 way Dual Activation GHRH-R (CJC-1295) + GHS-R1a (Ipamorelin) two complementary pituitary targets 2-4x GH AUC Demonstrated Synergy Area under the GH curve 2 to 4 times greater than each peptide in monotherapy 5.8 - 8.1 days CJC-1295 Half-Life Sustained elevation of IGF-1 for 9 to 11 days after a single injection 10 mg Pre-formulated mix 5 mg CJC-1295 (No DAC) + 5 mg Ipamorelin per vial | Purity 99% HPLC Selective Hormonal Profile Ipamorelin: no increase in cortisol, prolactin or ACTH (Raun et al., 1998) Mechanism of Action Dual-Channel Synergy Simultaneous activation of GHRH-R and GHS-R1a for amplified GH stimulation GHRH Lane CJC-1295 GHRH Analog (Mod GRF 1-29) A synthetic peptide of 29 amino acids that selectively binds to the GHRH receptor on pituitary somatotroph cells

They are also claimed to increase levels of adiponectin, a hormone that helps to regulate metabolism

Unlike traditional GLP-1 receptor agonists, tirzepatide is more selective for the GIP receptor, resulting in a more balanced activation of these receptors

On LifeMDs website, GLP-1s are featured prominently to advertise to potential customers

Consume grass-fed meat, grass-fed butter, wild-caught fish, and spirulina to get it in your diet